Schizophrenia
Schizophrenia
Pharmaceutical benefits that have the form olanzapine tablet 5 mg (orally disintegrating) and pharmaceutical benefits that have the form olanzapine wafer 5 mg are equivalent for the purposes of substitution.
For the purpose of administering this restriction, Schizophrenia refers to schizophrenia spectrum disorders outlined in the DSM-5 criteria.
Bipolar I disorder
Clinical criteria:
The treatment must be maintenance therapy.
Pharmaceutical benefits that have the form olanzapine tablet 5 mg (orally disintegrating) and pharmaceutical benefits that have the form olanzapine wafer 5 mg are equivalent for the purposes of substitution.
For the purpose of administering this restriction, Schizophrenia refers to schizophrenia spectrum disorders outlined in the DSM-5 criteria.